Trial intelligence / Profile preview

Pre-operative atorvastatin in elective abdominal aortic aneurysm repair

2004-004983-56Phase 4Completed

Sponsor
Hull University Teaching Hospitals
Start
Feb 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in ischemia-reperfusion injury (IRI) comparing Atorvastatin arm with Placebo arm (2 arms). Primary endpoint: Systemic and cellular markers of ischaemia reperfusion injury at 24 hours. Started Feb 2005; status: completed.

02

Drugs

atorvastatin
03

Conditions

ischemia-reperfusion injury (IRI)

Beyond the preview

Go deeper on 2004-004983-56.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-004983-56.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call